Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
70°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
131.75
+2.47 (+1.91%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 15, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
3
4
5
6
7
8
9
...
47
48
Next >
Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript
January 22, 2025
ABT earnings call for the period ending December 31, 2024.
Via
The Motley Fool
Topics
Earnings
Chipmakers Rally On AI Stargate Bet, Netflix Soars, Bitcoin Falters As Trump Keeps Quiet On Crypto: What's Driving Markets Wednesday?
January 22, 2025
Tech stocks enjoyed a surge Wednesday, driven by a sharp rise in semiconductor shares after President Donald Trump, OpenAI's Sam Altman, Oracle Corp.
Via
Benzinga
Topics
Artificial Intelligence
Government
Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall
January 22, 2025
Abbott's Q4 sales reached $10.97 billion, with 8.8% organic growth. EPS met expectations at $1.34, driven by strong performance in medical devices.
Via
Benzinga
How Is The Market Feeling About Abbott Laboratories?
December 30, 2024
Via
Benzinga
Peering Into Abbott Laboratories's Recent Short Interest
December 06, 2024
Via
Benzinga
ABBOTT LABORATORIES (NYSE:ABT) Technical Analysis observations.
December 02, 2024
Will ABBOTT LABORATORIES breakout?
Via
Chartmill
Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit
January 22, 2025
The company expects to earn an adjusted $5.05 to $5.25 per share this year, in line with forecasts for $5.16.
Via
Investor's Business Daily
US Stocks Likely To Open Higher As President Trump Announces $500 Billion AI Project: Oracle, Netflix, Nvidia Among Top Stocks To Watch
January 22, 2025
U.S. stocks could open on a positive note on Wednesday, continuing to rally after Donald Trump's inauguration as the 47th President of the U.S. on Monday.
Via
Benzinga
Topics
Artificial Intelligence
Government
Dow Jumps Over 500 Points As Trump Takes Office: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
January 22, 2025
The CNN Business Fear & Greed Index measures market sentiment, with higher fear putting pressure on stocks.
Via
Benzinga
Topics
Government
Stocks
Netflix, Procter & Gamble And 3 Stocks To Watch Heading Into Wednesday
January 22, 2025
Via
Benzinga
Earnings Scheduled For January 22, 2025
January 22, 2025
Via
Benzinga
Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever
January 21, 2025
Via
The Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
January 21, 2025
Via
The Motley Fool
3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Forever
January 21, 2025
Via
The Motley Fool
FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks: Food Stocks To Watch
January 15, 2025
The U.S. Food and Drug Administration announced a ban on Red No. 3, an artificial food coloring linked to cancer in animal studies, effective Jan. 15, 2027.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 14, 2025
Via
Benzinga
3 High-Yielding Dividend Stocks That Could Be Ideal Investments for Retirees
January 14, 2025
Via
The Motley Fool
8 Health Care Stocks Whale Activity In Today's Session
January 08, 2025
Via
Benzinga
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
January 07, 2025
Barclays analyst initiates Positive coverage on Anteris Technologies, forecasting a 4%-5% U.S. TAVR market share for DurAVR by 2030.
Via
Benzinga
2 No-Brainer Dividend Stocks to Buy With $250 in 2025
January 06, 2025
Via
The Motley Fool
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
January 04, 2025
Via
The Motley Fool
3 Dividend Growth Beasts That Have Raised Their Payouts for a Combined 165 Years
January 02, 2025
Via
The Motley Fool
2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
December 28, 2024
Via
The Motley Fool
10 Dividend Stocks For Intergenerational Wealth
December 27, 2024
The Dividend Aristocrats broadly have durable competitive advantages, and long-term growth.
Via
Talk Markets
Topics
Stocks / Equities
Introducing the "Dividend Seven" Stocks
December 24, 2024
Via
The Motley Fool
My Top 10 Stocks to Buy for 2025
December 21, 2024
Via
The Motley Fool
2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond
December 19, 2024
Via
The Motley Fool
The Smartest Dividend Stocks to Buy With $500 Right Now
December 18, 2024
Via
The Motley Fool
Jim Cramer Says 'Keep Owning' This Energy Stock, Abbott Laboratories 'Legal Stuff' Is Behind Them
December 11, 2024
Jim Cramer discusses Occidental Petroleum, Cooper Companies, Energy Transfer, Abbott, Kinder Morgan, Advanced Drainage and Archer Aviation.
Via
Benzinga
“Cardiol Therapeutics (NASDAQ: CRDL) Heart Health Innovation – AVCO, GXAI, UPC, and More Stocks Driving Groundbreaking Advances”
December 06, 2024
Via
AB Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
47
48
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.